These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7090358)

  • 41. Apple-Derived Pectin Modulates Gut Microbiota, Improves Gut Barrier Function, and Attenuates Metabolic Endotoxemia in Rats with Diet-Induced Obesity.
    Jiang T; Gao X; Wu C; Tian F; Lei Q; Bi J; Xie B; Wang HY; Chen S; Wang X
    Nutrients; 2016 Feb; 8(3):126. PubMed ID: 26938554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Beclobrate (Turec) in the treatment of primary hyperlipoproteinemia. II. Results of the treatment in relation to the type of hyperlipoproteinemia].
    Sznajd J; Idzior-Waluś B; Korzus G; Zabiński J; Hebda A; Markiewicz M
    Przegl Lek; 1990; 47(10):711-4. PubMed ID: 2089450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of coffee deprived of irritant substances upon some indices of lipid metabolism in healthy volunteers and patients with hyperlipoproteinemia.
    Hryniewiecki L; Hasik J; Grzymisławski M; Dobrowolska-Zachwieja A; Smolińska K; Adam W
    Mater Med Pol; 1992; 24(3):151-2. PubMed ID: 1307641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Soluble Fermentable Dietary Fibre (Pectin) Decreases Caloric Intake, Adiposity and Lipidaemia in High-Fat Diet-Induced Obese Rats.
    Adam CL; Thomson LM; Williams PA; Ross AW
    PLoS One; 2015; 10(10):e0140392. PubMed ID: 26447990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biliary lipid composition in normo- and hyperlipoproteinemia.
    Ahlberg J; Angelin B; Einarsson K; Hellström K; Leijd B
    Gastroenterology; 1980 Jul; 79(1):90-4. PubMed ID: 7380228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Nutritional therapy in disorders of lipid metabolism].
    Wolfram G
    Internist (Berl); 1992 Jan; 33(1):38-43. PubMed ID: 1551762
    [No Abstract]   [Full Text] [Related]  

  • 47. Acute lipidemic effect of calcium heparin in normolipemic and hyperlipemic subjects.
    Ferlito S; Ricceri M; Ossino AM
    Int Angiol; 1989; 8(3):140-4. PubMed ID: 2592796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A comparison of the hypolipidemic action of probucol at doses of 500 and 1000 mg/day in moderate hyperlipoproteinemia].
    Tvorogova MG; Lupanov VP; Nuraliev EIu; Zaĭtseva TM; Kukharchuk VV; Titov VN
    Ter Arkh; 1998; 70(8):17-21. PubMed ID: 9770737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Fibrinolytic capacity after exertion in atherogenic hyperlipoproteinemias].
    Zdrenghea D; Mărcuşu C; Cucuianu M; Rentsch S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):435-40. PubMed ID: 44567
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pregnancy induced changes in lipid-lipoprotein serum profile in women and newborn birth weight].
    Karoń J; Patek J; Głowacki J; Tomala J
    Ginekol Pol; 1996 Aug; 67(8):387-90. PubMed ID: 9139005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diagnosis of primary hyperlipoproteinemia during a preventive examination].
    Raslová K; Mongiellová V; Hucková M
    Cas Lek Cesk; 1993 Mar; 132(5):137-41. PubMed ID: 8472293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [High-density lipoprotein cholesterol and the atherogenic index in patients with different types of hyperlipoproteinemias].
    Apostolov I; Naumova R; Balabanski L; Goranov I
    Vutr Boles; 1983; 22(3):70-4. PubMed ID: 6649586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of diet and drug therapy on the level of high density lipoprotein cholesterol in patients with primary hyperlipoproteinemia].
    Padosh D; Kustosh D; Puchok I; Dem'ianova N; Audikovski M
    Klin Med (Mosk); 1981 Sep; 59(9):45-8. PubMed ID: 7311430
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical significance of arteriosclerosis indices of lipid metabolism and age dependence].
    Reuter W; Herrmann W; Voigt H; Köhler H; Schütz C; Hanf S; Lindhofer HG; Kuklinski B
    Z Alternsforsch; 1983; 38(5):361-7. PubMed ID: 6659565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of obesity with a high-protein, high-fat, "carbohydrate-free" diet].
    Tashev T; Goranov I; Ekimova S; Shishkov G; Dzhamba Ia
    Vutr Boles; 1976; 15(5):50-6. PubMed ID: 1014611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study.
    Domingo AJ; Gutiérrez JA; Menéndez JA; Micó L; Muñoz M; de Oya M
    Clin Ther; 1980; 3(3):219-26. PubMed ID: 7459931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pathogenic mechanisms of proatherogenic changes in pregnant women with concomitant obesity].
    Tarasenko KV; Mamontova TV
    Lik Sprava; 2013 Dec; (8):37-43. PubMed ID: 25726675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of a glucose load on lipid metabolic indices in coronary arteriosclerosis with varying types of hyperlipoproteinemia].
    Bobkova VI; Sidakova NM; Fomchenkov SI
    Kardiologiia; 1978 Mar; 18(3):66-73. PubMed ID: 642243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of a reduced diet on hyperlipoproteinemia in metabolic-alimentary obesity].
    Frolova IA; Oleneva VA; Zhukova LP
    Vopr Pitan; 1976; (5):39-43. PubMed ID: 185806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Physical work capacity of ischemic heart disease patients with various types of hyperlipoproteinemias].
    Zadionchenko VS; Kopalova SM
    Kardiologiia; 1980 Aug; 20(8):75-9. PubMed ID: 7412102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.